Terkko Navigator / Multiple Sclerosis and Related Disorders

The true burden of heart failure among multiple sclerosis patients: Addressing potential publication bias

Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders

Short report: Real-life analysis of the occurrence of persistent, transient, and fluctuating positive titres of neutralizing anti-drug antibodies in multiple sclerosis patients treated with interferon beta

German guideline for diagnosis and treatment of multiple sclerosis – a survey focusing neurologists in daily practise

Validation of two new scales for the assessment of fatigue in Multiple Sclerosis: F-2-MS and FACIT-F

Incomplete reporting of patient-reported outcomes in multiple sclerosis: A meta-epidemiological study of randomized controlled trials

Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis

Alemtuzumab induced hemodynamic change in relapsing multiple sclerosis occurs independent of corticosteroid premedication – a retrospective multicentre study

Prognosis of walking function in multiple sclerosis supported by gait pattern analysis

The effect of virtual reality-based therapy on fear of falling in multiple sclerosis: A systematic review and meta-analysis

Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis

Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: Impact of immunosuppressive treatment

Antibodies to blood coagulation components are implicated in patients with multiple sclerosis

Prevention or reduction of alemtuzumab-induced secondary autoimmune diseases through high-dose daily vitamin D supplementation?

Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies

The influence of socioeconomic factors on access to disease modifying treatment in a Norwegian multiple sclerosis cohort

Safety of Sinopharm vaccine for people with Multiple Sclerosis: Study of adverse reactions and disease activity

Progressive retinal changes in pediatric multiple sclerosis

Aerobic exercise increases irisin serum levels and improves depression and fatigue in patients with relapsing remitting multiple sclerosis: A randomized controlled trial

Personality and its association with self-management in multiple sclerosis

Sociodemographic and clinical characteristics of people with multiple sclerosis and neuro-myelitis optica spectrum disorder in a central northern region of Chile: A prevalence study

Neuromyelitis optica spectrum disorder in Western Mexico

Reply to correspondence “Regional (but strategic) assessment for a generalized disorder (Sarcopenia)”

Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications

COVID-19 in neuromyelitis optica spectrum disorder patients in Poland

Real-world disease-modifying therapy usage in persons with relapsing-remitting multiple sclerosis: Cross-sectional data from the Swiss Multiple Sclerosis Registry

Centrally-located transverse myelitis would facilitate the differentiation of NMOSD and MOG-AD from MS

Prospective associations of better quality of the diet with improved quality of life over 7.5 years in people with multiple sclerosis

Temporal Incidence and Prevalence Trends of Multiple Sclerosis in Markazi Province, Iran

Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residents

Type of serum collection tube does not impact neurofilament light chain levels

Regional (but strategic) assessment for a generalized disorder (Sarcopenia)

Practical issues concerning the use of Magnetic Resonance Imaging in Multiple Sclerosis in Latin America: Discussion from 16 centres on behalf of the Foro Latam EM Study Group

Hypogonadism in men with multiple sclerosis: Prevalence and clinical associations

To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England

High or increasing serum NfL is predictive of impending multiple sclerosis relapses

Pediatric neuromyelitis optica spectrum disorders in Portugal: A multicentre retrospective study

It's time to talk about disclosure and concealment in MS

Gastrointestinal pathologic findings of teriflunomide associated diarrhea

Myocardial infarction and stroke risks in multiple sclerosis patients: A two-sample Mendelian randomization study

The Heimann-Bielschowsky phenomenon after optic neuritis

Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis

Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, Canada

Elsberg syndrome following acute immunosuppressive treatment for multiple sclerosis relapse

Neglected aspect: Some points on how to deal with cognitive disorders in people with multiple sclerosis

Prodromal emesis in MOG-antibody associated disorder

Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: Evaluation of 794 attacks from a nationwide registry in Argentina

Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects

A patient-centred evaluation of phantom skin wetness as a sensory symptom in people with multiple sclerosis

Tunisian version of the brief international cognitive assessment for multiple sclerosis: Validation and normative values